DuPont de Nemours, Inc.

DB:6D81 Stock Report

Market Cap: €33.4b

DuPont de Nemours Valuation

Is 6D81 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6D81 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6D81 (€78.84) is trading below our estimate of fair value (€147.88)

Significantly Below Fair Value: 6D81 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6D81?

Key metric: As 6D81 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 6D81. This is calculated by dividing 6D81's market cap by their current earnings.
What is 6D81's PE Ratio?
PE Ratio68.6x
EarningsUS$508.00m
Market CapUS$34.82b

Price to Earnings Ratio vs Peers

How does 6D81's PE Ratio compare to its peers?

The above table shows the PE ratio for 6D81 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.6x
SY1 Symrise
37.8x13.2%€14.8b
EVK Evonik Industries
35.8x33.1%€8.2b
WCH Wacker Chemie
28.3x37.0%€3.5b
BAS BASF
76.5x34.2%€38.0b
6D81 DuPont de Nemours
68.6x23.7%€34.8b

Price-To-Earnings vs Peers: 6D81 is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the peer average (44.6x).

Price to Earnings Ratio vs Industry

How does 6D81's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
6D81 68.6xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 6D81 is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is 6D81's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6D81 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio68.6x
Fair PE Ratio24.1x

Price-To-Earnings vs Fair Ratio: 6D81 is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the estimated Fair Price-To-Earnings Ratio (24.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6D81 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€78.84
€91.58
+16.2%
13.2%€102.08€49.61n/a16
Nov ’25€76.17
€87.48
+14.8%
13.2%€97.09€48.08n/a17
Oct ’25€79.69
€83.67
+5.0%
13.2%€94.04€46.57n/a17
Sep ’25€74.78
€84.69
+13.3%
13.1%€95.49€47.29n/a17
Aug ’25€75.92
€85.32
+12.4%
13.0%€97.30€48.19n/a17
Jul ’25€74.69
€83.12
+11.3%
13.1%€95.37€48.15n/a17
Jun ’25€75.00
€83.12
+10.8%
13.1%€95.37€48.15n/a17
May ’25€68.79
€74.59
+8.4%
11.9%€84.18€48.64n/a16
Apr ’25€70.40
€70.27
-0.2%
13.3%€92.54€48.12n/a16
Mar ’25€63.88
€70.39
+10.2%
13.0%€93.38€48.56n/a16
Feb ’25€57.14
€70.17
+22.8%
13.4%€92.33€48.01n/a16
Jan ’25€69.44
€72.77
+4.8%
12.4%€83.62€44.54n/a16
Dec ’24€65.44
€71.63
+9.5%
12.8%€83.75€44.60n/a16
Nov ’24€64.50
€74.83
+16.0%
14.8%€87.06€46.37€76.1717
Oct ’24€70.36
€76.32
+8.5%
12.6%€86.10€45.86€79.6917
Sep ’24€70.80
€74.75
+5.6%
12.3%€84.08€44.78€74.7818
Aug ’24€70.88
€70.47
-0.6%
11.9%€82.93€44.17€75.9218
Jul ’24€64.98
€70.53
+8.5%
12.4%€84.36€47.68€74.6919
Jun ’24€62.78
€72.27
+15.1%
12.6%€86.08€48.66€75.0018
May ’24€62.16
€76.37
+22.9%
12.6%€94.23€47.57€68.7917
Apr ’24€64.62
€77.24
+19.5%
12.8%€94.44€47.68€70.4017
Mar ’24€68.42
€79.73
+16.5%
14.0%€97.63€42.66€63.8818
Feb ’24€67.71
€73.60
+8.7%
14.8%€94.39€41.24€57.1419
Jan ’24€64.09
€75.04
+17.1%
14.8%€97.19€42.46€69.4419
Dec ’23€67.00
€75.17
+12.2%
13.9%€91.75€43.46€65.4418
Nov ’23€60.00
€71.51
+19.2%
17.4%€97.10€45.99€64.5018

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

HGR

UK£0.76

7D

-1.4%

1Y

-29.4%

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.91

7D

2.1%

1Y

-15.5%

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.55

7D

-5.4%

1Y

-19.6%